Literature DB >> 12479629

An in vitro model of ciprofloxacin and minocycline transport by oral epithelial cells.

James J Brayton1, Qing Yang, Robin J Nakkula, John D Walters.   

Abstract

BACKGROUND: Fluoroquinolones and tetracyclines can penetrate epithelial cells, but the mechanism by which they cross the plasma membrane is unclear. In this study, a cell line derived from oral epithelium was used as a model to demonstrate a role for active transport.
METHODS: Transport of ciprofloxacin and minocycline by confluent cell monolayers was assayed by measuring the increase in cell-associated fluorescence.
RESULTS: Uptake of both agents was saturable and was inhibited at low temperatures. At 37 degrees C, the cells transported ciprofloxacin and minocycline with Km values of 351 and 133 microg/ml, respectively, and maximum velocities of 5.11 and 13.4 ng/min/microg cell protein, respectively. When ciprofloxacin and minocycline were removed from the extracellular medium, the intracellular levels of both agents decreased. Ciprofloxacin efflux from loaded cells occurred more rapidly than with minocycline. Cells accumulated intracellular drug levels that were at least 8-fold higher than extracellular levels for ciprofloxacin and at least 40-fold higher for minocycline. Transport of ciprofloxacin and minocycline was significantly influenced by pH and was most favorable at pH 7.7 and 7.2, respectively. While ciprofloxacin transport was Na+ independent, minocycline transport was strongly inhibited when sodium in the medium was replaced with choline. Transport of both agents was inhibited by a variety of organic cations, but the pattern of inhibition was different. Papaverine, phenylephrine, and doxycycline competitively inhibited minocycline transport, but inhibited ciprofloxacin transport by a non-competitive mechanism.
CONCLUSIONS: Epithelial cells take up ciprofloxacin and minocycline via different active transport systems. These transporters may play an important role in enhancing the effectiveness of these agents against invasive pathogens.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12479629      PMCID: PMC2483302          DOI: 10.1902/jop.2002.73.11.1267

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  32 in total

1.  In vitro susceptibilities of Actinobacillus actinomycetemcomitans to a number of antimicrobial combinations.

Authors:  M J Pavicić; A J van Winkelhoff; J de Graaff
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

2.  In vitro and in vivo ciprofloxacin pharmacokinetics in human neutrophils.

Authors:  R Garraffo; D Jambou; R M Chichmanian; S Ravoire; P Lapalus
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

3.  Invasion of epithelial cells by Actinobacillus actinomycetemcomitans: a dynamic, multistep process.

Authors:  D H Meyer; J E Lippmann; P M Fives-Taylor
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

Review 4.  Nucleoside and nucleobase transport systems of mammalian cells.

Authors:  D A Griffith; S M Jarvis
Journal:  Biochim Biophys Acta       Date:  1996-10-29

5.  Fluxes and accumulation of tetracyclines by human blood cells.

Authors:  W L Gabler
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1991-04

6.  Uptake and intracellular activity of trovafloxacin in human phagocytes and tissue-cultured epithelial cells.

Authors:  A Pascual; I García; S Ballesta; E J Perea
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

7.  Porphyromonas gingivalis invasion of gingival epithelial cells.

Authors:  R J Lamont; A Chan; C M Belton; K T Izutsu; D Vasel; A Weinberg
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

8.  Interaction of Porphyromonas gingivalis with gingival epithelial cells maintained in culture.

Authors:  R J Lamont; D Oda; R E Persson; G R Persson
Journal:  Oral Microbiol Immunol       Date:  1992-12

9.  Topical chemotherapy in human periodontitis using a new controlled-release insert containing ofloxacin. I. Microbiological observation.

Authors:  S Kimura; H Toda; Y Shimabukuro; M Kitamura; N Fujimoto; Y Miki; H Okada
Journal:  J Periodontal Res       Date:  1991-01       Impact factor: 4.419

10.  In vitro antimicrobial susceptibility of different serotypes of Actinobacillus actinomycetemcomitans.

Authors:  R Pajukanta; S Asikainen; M Saarela; S Alaluusua; H Jousimies-Somer
Journal:  Scand J Dent Res       Date:  1993-10
View more
  12 in total

1.  Characterization of minocycline transport by human neutrophils.

Authors:  John D Walters
Journal:  J Periodontol       Date:  2006-12       Impact factor: 6.993

2.  Azithromycin kills invasive Aggregatibacter actinomycetemcomitans in gingival epithelial cells.

Authors:  Pin-Chuang Lai; John D Walters
Journal:  Antimicrob Agents Chemother       Date:  2012-12-28       Impact factor: 5.191

Review 3.  Should Antibiotics Be Prescribed to Treat Chronic Periodontitis?

Authors:  John Walters; Pin-Chuang Lai
Journal:  Dent Clin North Am       Date:  2015-08-01

4.  P-glycoprotein-mediated transport of moxifloxacin in a Calu-3 lung epithelial cell model.

Authors:  Julien Brillault; Whocely Victor De Castro; Thomas Harnois; Alain Kitzis; Jean-Christophe Olivier; William Couet
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

5.  Esculentin-1a-Derived Peptides Promote Clearance of Pseudomonas aeruginosa Internalized in Bronchial Cells of Cystic Fibrosis Patients and Lung Cell Migration: Biochemical Properties and a Plausible Mode of Action.

Authors:  Floriana Cappiello; Antonio Di Grazia; Li-Av Segev-Zarko; Silvia Scali; Loretta Ferrera; Luis Galietta; Alessandro Pini; Yechiel Shai; Y Peter Di; Maria Luisa Mangoni
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

6.  Accumulation of topical naproxen by cultured oral epithelium.

Authors:  R R Fitzgerald; J D Walters
Journal:  J Dent Res       Date:  2007-08       Impact factor: 6.116

Review 7.  Acetylcholine and the alpha 7 nicotinic receptor: a potential therapeutic target for the treatment of periodontal disease?

Authors:  Noha Zoheir; David F Lappin; Christopher J Nile
Journal:  Inflamm Res       Date:  2012-07-10       Impact factor: 4.575

8.  Minocycline as heart conditioning agent in experimental type 2 diabetes mellitus - an antibacterial drug in heart protection.

Authors:  Nikola M Sobot; Tanja S Sobot; Jovana N Jeremic; Sergey B Bolevich; Stefani S Bolevich; Slobodanka Lj Mitrovic; Vladimir P Fisenko; Sofija G Inic; Andjela D Milojevic Samanovic; Marina R Rankovic; Ivan M Srejovic; Vladimir I Zivkovic; Vladimir Lj Jakovljevic
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-02-03       Impact factor: 3.000

9.  The alpha 7 nicotinic receptor agonist PHA-543613 hydrochloride inhibits Porphyromonas gingivalis-induced expression of interleukin-8 by oral keratinocytes.

Authors:  Alexandrea Macpherson; Noha Zoheir; Raja Azman Awang; Shauna Culshaw; Gordon Ramage; David F Lappin; Christopher J Nile
Journal:  Inflamm Res       Date:  2014-03-08       Impact factor: 4.575

10.  Relative effectiveness of azithromycin in killing intracellular Porphyromonas gingivalis.

Authors:  Pin-Chuang Lai; John D Walters
Journal:  Clin Exp Dent Res       Date:  2016-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.